ES2091262T3 - Uso de magnesio-piridoxal-5'-fosfato-glutaminato para la prevencion de enfermedades que resultan de lesiones vasculares. - Google Patents

Uso de magnesio-piridoxal-5'-fosfato-glutaminato para la prevencion de enfermedades que resultan de lesiones vasculares.

Info

Publication number
ES2091262T3
ES2091262T3 ES91108217T ES91108217T ES2091262T3 ES 2091262 T3 ES2091262 T3 ES 2091262T3 ES 91108217 T ES91108217 T ES 91108217T ES 91108217 T ES91108217 T ES 91108217T ES 2091262 T3 ES2091262 T3 ES 2091262T3
Authority
ES
Spain
Prior art keywords
glutaminate
phosphate
magnesium
piridoxal
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91108217T
Other languages
English (en)
Inventor
Werner Dr Rer Nat Schneider
Britta Meyer
Erich F Prof Dr Elstner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Steigerwald Arzneimittelwerk GmbH
Original Assignee
Steigerwald Arzneimittelwerk GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steigerwald Arzneimittelwerk GmbH filed Critical Steigerwald Arzneimittelwerk GmbH
Application granted granted Critical
Publication of ES2091262T3 publication Critical patent/ES2091262T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION SE REFIERE AL USO DE MAGNESIO-PIRIDOXAL-5''-FOSFATO -GLUTAMINATO PARA PREPARAR UN COMPUESTO FARMACEUTICO PARA REDUCIR LOS PEROXIDOS DE ENLACE LDL Y PARA LA PROFILAXIS DE LESIONES VASCULARES RESULTANTE DE LAS MISMAS EN AUSENCIA DE HIPERCOLESTEREMIA O HIPERLIPIDEMIA.
ES91108217T 1990-05-25 1991-05-22 Uso de magnesio-piridoxal-5'-fosfato-glutaminato para la prevencion de enfermedades que resultan de lesiones vasculares. Expired - Lifetime ES2091262T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4016963A DE4016963A1 (de) 1990-05-25 1990-05-25 Verwendung von magnesium-pyridoxal-5'-phosphat-glutaminat zur verhinderung von erkrankungen, die sich infolge von gefaessschaeden ergeben

Publications (1)

Publication Number Publication Date
ES2091262T3 true ES2091262T3 (es) 1996-11-01

Family

ID=6407228

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91108217T Expired - Lifetime ES2091262T3 (es) 1990-05-25 1991-05-22 Uso de magnesio-piridoxal-5'-fosfato-glutaminato para la prevencion de enfermedades que resultan de lesiones vasculares.

Country Status (28)

Country Link
US (1) US5372999A (es)
EP (1) EP0458287B1 (es)
JP (1) JPH07119174B2 (es)
KR (1) KR970005180B1 (es)
CN (1) CN1050750C (es)
AT (1) ATE142884T1 (es)
AU (1) AU651108B2 (es)
CA (1) CA2043228C (es)
CZ (1) CZ280683B6 (es)
DE (2) DE4016963A1 (es)
DK (1) DK0458287T3 (es)
EG (1) EG19730A (es)
ES (1) ES2091262T3 (es)
GR (1) GR3021077T3 (es)
HR (1) HRP931445B1 (es)
HU (1) HU219223B (es)
IE (1) IE76728B1 (es)
IL (1) IL98156A (es)
IN (1) IN173057B (es)
LT (1) LT3335B (es)
LV (1) LV10046B (es)
MD (1) MD306C2 (es)
MX (1) MX171883B (es)
RU (1) RU2041713C1 (es)
SI (1) SI9110925A (es)
SK (1) SK278896B6 (es)
UA (1) UA26973A1 (es)
ZA (1) ZA913692B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19527820A1 (de) * 1995-07-28 1997-01-30 Leniger Follert Elfriede Prof Arzneimittel zur Behandlung von Ulcera, insbesondere bei arteriellen und venösen Durchblutungsstörungen der Extremitäten, bei chronisch venöser Insuffizienz und Lymphödem
DE19532625C2 (de) * 1995-09-04 2000-04-20 Steigerwald Arzneimittelwerk Verfahren zur Herstellung von Magnesium-pyridoxal-5'-phosphat-glutamat und dabei erhaltene Zwischenprodukte
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
US6339085B1 (en) 1999-03-08 2002-01-15 The University Of Manitoba Therapeutics for cardiovascular and related diseases
US6489345B1 (en) 1999-07-13 2002-12-03 Medicure, Inc. Treatment of diabetes and related pathologies
CA2383252A1 (en) * 1999-08-24 2001-03-01 Medicure International Inc. Treatment of cardiovascular related pathologies
PT1268498E (pt) 2000-02-29 2005-07-29 Medicure Int Inc Fosfonatos cardioprotectores
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
JP2003528146A (ja) 2000-03-28 2003-09-24 メディキュア インターナショナル インコーポレイテッド 脳血管疾患の治療
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
NZ523815A (en) 2000-07-07 2004-07-30 Medicure Int Inc Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
AU2005304220A1 (en) 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
US7459468B2 (en) 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
CA2680801A1 (en) 2007-03-14 2008-09-18 Sierra Molecular Corporation Compositions, systems, and methods for preservation and/or stabilizationof a cell and/or macromolecule
RU2484843C1 (ru) * 2012-04-03 2013-06-20 Алексей Кириллович Пехтерев Лекарственный сбор растений для лечения сердечно-сосудистых заболеваний

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE246172C (es)
DE2461742C2 (de) * 1974-12-28 1983-01-27 Steigerwald Arzneimittelwerk Gmbh, 6100 Darmstadt Pyridoxin-5'-phosphorsäureester-Derivate sowie deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3807895A1 (de) * 1988-03-10 1989-09-21 Knoll Ag Erzeugnisse, enthaltend einen calciumantagonisten und einen lipidsenker

Also Published As

Publication number Publication date
GR3021077T3 (en) 1996-12-31
HU911756D0 (en) 1991-12-30
LT3335B (en) 1995-07-25
LV10046A (lv) 1994-05-10
LTIP580A (en) 1994-12-27
DE69122170T2 (de) 1997-02-20
EP0458287A2 (en) 1991-11-27
CS156391A3 (en) 1992-02-19
AU7730191A (en) 1991-11-28
JPH07119174B2 (ja) 1995-12-20
UA26973A1 (uk) 2000-02-28
KR910019616A (ko) 1991-12-19
KR970005180B1 (ko) 1997-04-14
RU2041713C1 (ru) 1995-08-20
HRP931445B1 (en) 2000-04-30
MD306B1 (ro) 1995-10-31
CZ280683B6 (cs) 1996-04-17
MX171883B (es) 1993-11-22
ZA913692B (en) 1992-02-26
IE911783A1 (en) 1991-12-04
US5372999A (en) 1994-12-13
EP0458287B1 (en) 1996-09-18
CA2043228A1 (en) 1991-11-26
IN173057B (es) 1994-02-05
CA2043228C (en) 1998-07-14
DE4016963C2 (es) 1992-04-30
IL98156A0 (en) 1992-06-21
EG19730A (en) 1996-01-31
DE69122170D1 (de) 1996-10-24
LV10046B (en) 1995-02-20
SI9110925A (sl) 1998-06-30
CN1050750C (zh) 2000-03-29
CN1057391A (zh) 1992-01-01
MD306C2 (ro) 1996-02-29
HU219223B (en) 2001-03-28
IE76728B1 (en) 1997-11-05
DK0458287T3 (da) 1996-10-07
JPH04235130A (ja) 1992-08-24
DE4016963A1 (de) 1991-11-28
HUT58204A (en) 1992-02-28
SK278896B6 (sk) 1998-04-08
HRP931445A2 (en) 1996-02-29
EP0458287A3 (en) 1992-04-08
AU651108B2 (en) 1994-07-14
IL98156A (en) 1996-06-18
ATE142884T1 (de) 1996-10-15

Similar Documents

Publication Publication Date Title
ES2091262T3 (es) Uso de magnesio-piridoxal-5'-fosfato-glutaminato para la prevencion de enfermedades que resultan de lesiones vasculares.
DE69117117D1 (de) Reinigungszusammensetzung zur Vorbeugung und Milderung von Hautreizungen
ES2060310T3 (es) Utilizacion de la n-miristoil-(s)-fenilalanina para la obtencion de medicamentos destinados al tratamiento de enfermedades que hacen intervenir la miristoilacion.
FI962685A0 (fi) 2,3-diaryyli-1-bentsopyraanijohdannaisten käyttö lääkkeen valmistamiseksi luukadon ja osteoporoosin hoitamiseksi ja estämiseksi
ZA8993B (en) Medical treatment
MX9304185A (es) Producto y composicion farmaceutica que lo contiene para el tratamiento de la mastitis y la mestritis bovina.
ES2181054T3 (es) Utilizacion de producto(s) proteico(s) kgf y de producto(s) proteico(s) glp-2 para la preparacion de un medicamento.
ES2150418T3 (es) Composiciones farmaceuticas que comprenden calcitonina.
TR199902335T2 (xx) Vask�ler bozukluklar�n tedavisi.
ES2101311T3 (es) Utilizacion de un dispositivo transdermico que contiene (e)-2-(p-fluorofenetil)-3-fluoroalilamina y su uso para el tratamiento de la enfermedad de alzheimer.
ES2188742T3 (es) Trapidil para uso en la terapia de cuadros patologicos influenciables por la inmunomodulacion.
SE8900564D0 (sv) Novel medicinal use
ES2147576T3 (es) Utilizacion del efaroxan y de sus derivados para la preparacion de un medicamento destinado al tratamiento de la enfermedad de parkinson.
ITMI913231A0 (it) Bisturi ad elevata sicurezza contro la possibilita' di ferimenti accidentali
SE9403861D0 (sv) Novel medicinal use
ITMI910442V0 (it) Struttura di zoccolo ortopedico, o simile, in particolare per la prevenzione o la cura del valgismo dell'alluce
IT8919204A0 (it) Composizione per la prevenzione e la cura di parodontopatte.
ES1025668Y (es) Protector contra las ulceraciones de las articulaciones en pacientes que deben permanecer inmoviles.
ITMI910114V0 (it) Struttura di calza ortopedica in particolare per la cura e la prevenzione del valgismo dell'alluce
LV5179A3 (lv) Preparats "etoksidins" teju kunga un zarnu slimibu profilaksei un arstesanai
ITGE910094A0 (it) Prodotto per la cura e la prevenzione del cancro e dell'aids

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 458287

Country of ref document: ES